Viemed Healthcare (VMD) Invested Capital (2018 - 2026)

Viemed Healthcare has reported Invested Capital for 9 years, with the latest figure at $146.7 million in Q1 2026.

• For the quarter ending Q1 2026, Invested Capital rose 6.95% year-over-year to $146.7 million; the trailing twelve-month figure through Mar 2026 stood at $146.7 million (up 6.95% YoY), and the FY2025 full-year result was $144.6 million, up 8.15% from the prior year.
• Invested Capital for Q1 2026 stood at $146.7 million, up from $144.6 million in the prior quarter.
• The five-year high for Invested Capital was $146.7 million in Q1 2026, with the low at $97.1 million in Q4 2022.
• Historically, Invested Capital has averaged $119.5 million across 5 years, with a median of $116.9 million in 2024.
• Annual changes were most pronounced in 2022 — Invested Capital declined 3.49% — and 2023, when it gained 18.41%.
• Viemed Healthcare's Invested Capital stood at $97.1 million in 2022, then gained by 18.41% to $115.0 million in 2023, then increased by 16.3% to $133.7 million in 2024, then increased by 8.15% to $144.6 million in 2025, then rose by 1.42% to $146.7 million in 2026.
• The last three Invested Capital figures came in at $146.7 million (Q1 2026), $144.6 million (Q4 2025), and $137.0 million (Q3 2025), per Business Quant data.